Graph Neural Networks Cancer Pathway Analysis

Graph Neural Network Architectures for Protein Interaction Mapping

This research investigates novel GNN architectures specifically designed to model dynamic protein-protein interactions within cancer signaling pathways. The work produces fundamental insights into how message-passing mechanisms can capture multi-scale biological dependencies and identify critical hub proteins in oncogenic networks.

Heterogeneous Graph Learning for Multi-Omics Cancer Data Integration

This research explores heterogeneous graph neural networks that integrate genomic, transcriptomic, proteomic, and metabolomic data as distinct node and edge types. The scientific contribution reveals emergent pathway relationships and synergistic biomarkers invisible to single-omics approaches.

Attention Mechanisms in Cancer Pathway Graph Representation Learning

This research develops graph attention networks that learn interpretable weights for pathway components, revealing which molecular interactions drive cancer phenotypes. The work generates novel hypotheses about pathway rewiring by explicitly visualizing learned attention patterns across tumor samples.

Temporal Graph Neural Networks for Longitudinal Cancer Progression Modeling

This research applies temporal and dynamic graph neural networks to track how cancer pathways evolve across disease stages and treatment trajectories. The contribution provides predictive models of pathway plasticity and reveals critical temporal windows for therapeutic intervention.

Graph Convolutional Networks for Somatic Mutation Pathway Impact Assessment

This research uses graph convolutional networks to propagate somatic mutation effects through cancer signaling pathways and assess functional impact beyond individual variant analysis. The scientific insight quantifies how mutation burden distributes across pathway neighborhoods and predicts clonal dominance.

Knowledge Graph Embedding Methods for Cancer Mechanistic Hypothesis Generation

This research develops graph embedding techniques that integrate curated cancer biology knowledge bases with experimental data to generate novel mechanistic hypotheses. The work produces candidate pathway interactions and drug target combinations ranked by graph-derived biomedical plausibility scores.

Graph Neural Network Approaches for Immunotherapy Pathway Response Prediction

This research applies GNNs to model interactions between tumor intrinsic pathways and immune microenvironment signaling to predict immunotherapy outcomes. The contribution identifies pathway configurations associated with T-cell infiltration and anti-tumor immunity through joint pathway-immune graph analysis.

Explainable Graph Neural Networks for Cancer Driver Gene Discovery

This research develops explainability methods for GNNs to identify and validate novel cancer driver genes by analyzing their pathway neighborhood influence. The scientific contribution provides graph-derived evidence linking candidate drivers to known oncogenic pathways with biological interpretability.

Graph Signal Processing for Pathway Robustness and Redundancy Analysis

This research applies graph signal processing techniques to analyze how cancer pathways maintain functionality through redundant connections and bypass mechanisms. The work quantifies pathway robustness metrics and identifies critical nodes whose disruption maximally impairs cancer survival.

Subgraph Neural Networks for Patient-Specific Cancer Pathway Rewiring Detection

This research employs subgraph neural networks to identify patient-specific pathway rewiring events that drive personalized cancer phenotypes. The contribution reveals how pathway modules are reactivated, repressed, or rerouted in individual tumors, enabling precision oncology pathway profiling.